摘要
目的:通过本地区人群骨密度的临床观察,研究QCT骨矿密度(bone mineral density,BMD)测定在临床中的应用,探讨骨质疏松(Osteoporosis,OP)的诊断方法,旨在提高骨质疏松的防治水平。方法:使用德国SIEMENS SOMA-TOM AR nova QCT,对2003年8月～2011年5月骨密度检测人群进行列表、分类并分析。结果:2784例BMD测定,其中骨量减少816例,轻度骨质疏松521例,中度骨质疏松249例,重度骨质疏松70例。结论:QCT对骨质疏松(OP)有重要的诊断价值,可对OP患者进行分类,对中老年人群中的OP患者防治方法的筛选以及对OP的治疗疗效监测有重要指导意义。QCT检测BMD对健康人群的骨钙含量有测定作用。QCT骨矿密度(BMD)测定骨骼矿物质含量具有临床应用前景和潜力。
Objective： Through the clinical observation of the local people＇s bone mineral density, the clinical application of the quantitative CT （QCT） and the bone mineral density （BMD） were determined and the osteoporosis （OP） diagnostic method was discussed to improve the prevention and cure level. Methods Listing, classification and analysis of testing ca- ses had been conducted from August, 2003 to May, 201t by means of German SIEMENS SOMATOM AR nova QCT. Re- sults：Among 2784 cases, there Were 816 with bone loss in BMD, 521 with mild OP, 249 with moderate OP, and 70 with severe OP. Conclusion：QCT is of significant diagnostic value for OP and of great importance for classification of both mid- dle aged and elderly patients and screening in prevention and treatment, especially is of great instructive meaning for moni- toring the OP treatment effect. QCT determination can help test bone calcium content of healthy people. QCT determina- tion of BMD has a broad prospect and potential in clinical application.
出处
《医学影像学杂志》
2011年第12期1892-1895,共4页
Journal of Medical Imaging
